Teaching Video NeuroImage: Reversible Parkinsonism Caused by Lumboperitoneal Shunt Overdrainage
Citation Manager Formats
Make Comment
See Comments

Case
A 51-year-old woman presented with apraxia of eyelid opening, followed by slowly progressive masked facies, tongue tremor, dysphagia, neck and upper extremity rigidity, and bradykinesia 6 months after lumboperitoneal shunt placement for hydrocephalus after subarachnoid hemorrhage. An MRI examination of the brain showed midbrain compression, brainstem displacement inferiorly, and cistern effacement, consistent with infratentorial hypotension. 123I-ioflupane SPECT imaging showed reduced striatal dopamine transporter binding bilaterally. All symptoms and findings ameliorated after increasing shunt pressure (Figures 1 and 2 and Video 1). UPDRS Part III score improved from 24 to 5. Intracranial hypotension with midbrain sagging can cause reversible parkinsonism1,2 when displacement shear forces impair the nigrostriatal dopamine pathway.
Initial axial T2-weighted imaging (A) and sagittal T1-weighted imaging (B) show marked midbrain compression (dashed arrows), brainstem sagging (arrowhead), inferior drooping of the splenium (arrow), narrowing of the fourth ventricle (yellow arrowhead), and cerebellar tonsillar herniation (yellow arrow). (C, D) After shunt pressure adjustment, structures around the brain stem recovered.
Initial SPECT (A) demonstrates impaired dopamine transporter binding in the bilateral striata, which recovered after shunt pressure adjustment (B). The SBR (specific binding ratio) values were obtained using the Tossici-Bolt method (SBRBolt). Red lines represent the mean SBR by age and purple and green lines the 95% upper and lower prediction intervals.
Video 1
Video demonstrating apraxia of eyelid opening and reduced arm swing during walking before shunt pressure adjustment. After shunt pressure adjustment, these findings were almost resolved.Download Supplementary Video 1 via http://dx.doi.org/10.1212/200994_Video_1
Study Funding
This study was funded by Grants-in Aid from the Research Committee of CNS Degenerative Diseases, Research on Policy Planning and Evaluation for Rare and Intractable Diseases, Health, Labour and Welfare Sciences Research Grants, the Ministry of Health, Labour and Welfare, Japan (Grant Number 20FC1049).
Disclosure
The authors report no relevant disclosures. Go to Neurology.org/N for full disclosures.
Acknowledgment
The authors thank Rinako Shimada at Kyushu University and Edanz (jp.edanz.com/ac) for editing a draft of this article.
Appendix Authors

Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Submitted and externally peer reviewed. The handling editor was Roy Strowd III, MD, Med, MS.
Teaching slides links.lww.com/WNL/C179
- Received February 24, 2022.
- Accepted in final form June 8, 2022.
- © 2022 American Academy of Neurology
References
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan
Related Articles
- No related articles found.